An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
10.1021/acsbiomaterials.2c00202
Saved in:
Main Authors: | Chua, Koon Jiew, Ling, Hua, Hwang, In Young, Lee, Hui Ling, March, John C, Lee, Yung Seng, Chang, Matthew Wook |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Language: | English |
Published: |
AMER CHEMICAL SOC
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239198 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Development of probiotic nanovesicles for oral delivery in inflammatory bowel disease (IBD) treatment
by: Lin, Xiang
Published: (2024) -
MODELING GASTROINTESTINAL MOTILITY DISORDERS AND INFLAMMATION IN AN INTESTINE MICROPHYSIOLOGICAL SYSTEM
by: JANANI SICKHAN PONNAMBALAM
Published: (2024) -
DUSP4 REGULATES INTESTINAL INFLAMMATION AND TUMORIGENESIS
by: LU YI
Published: (2020) -
SOCIAL CONSTRAINTS AND LIVED EXPERIENCES IN SCHOOL: AN EXPLORATORY STUDY ON ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE IN SINGAPORE
by: DARRYL WONG WAI BIN
Published: (2020) -
Complementary and alternative medicine (CAM) practices and dietary patterns in children with inflammatory bowel disease in Singapore and Malaysia
by: Ong, F., et al.
Published: (2022)